Drugs / TAK-648
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02480439 | Jun → Aug 2015 | — | Takeda | Completed | No outcome recorded |
| Phase 1 | NCT02430870 | Apr → Sep 2015 | type 2 diabetes mellitus | Takeda | Completed | No outcome recorded |
| Phase 1 | NCT02684396 | Aug 2014 → Apr 2015 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-648 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02430870 ↗ |
| Route | Oral | “administered as multiple oral doses of TAK-648 solution” NCT02430870 ↗ |